跳至主要内容
临床试验/NCT01053975
NCT01053975终止不适用

SPIROCOR Coronary Outcome by Respiratory Stress Examination - SCORE Study

Spirocor26 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
1,000
试验地点
26
主要终点
RSR vs. S-ECG in subjects suspected with S-CAD

研究概览

简要总结

The purpose of this study is to validate the accuracy of the SPIROCOR System in indicating the presence of significant coronary artery disease (S-CAD), as defined in ACC/AHA Guidelines, in subjects with suspected S-CAD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject with suspected S-CAD
  • Subject able to perform the guided breathing protocol and comply with study requirements
  • Subject is able and agrees to sign the informed consent form

排除标准

  • Resting (supine) ECG evidence of ST-segment depression ≥ 1 mm in any lead or left bundle branch block or significant arrhythmia
  • Current digoxin therapy
  • Subject has severe valvular heart disease
  • Subject has congestive heart failure NYHA class III/IV
  • Subject has known history of myocardial infarction (ST elevation or non ST elevation)
  • Subject had previous coronary revascularization: CABG or PCI
  • Subject has pacemaker or ICD that controls sinus
  • Morbidly obese subject (BMI ≥ 40)
  • Subject has any significant medical condition which, at the investigator's discretion, may interfere with the subject's optimal participation in the study; and
  • Subject is currently participating in another investigational product clinical study that the investigator believes may interfere with the outcome of this study

结局指标

主要结局

RSR vs. S-ECG in subjects suspected with S-CAD

时间窗: 3 weeks window

次要结局

未报告次要终点

研究者

发起方
Spirocor
申办方类型
Industry

研究点 (26)

Loading locations...

相似试验